Benzbromarone withdrawn from the European market: another case of "absence of evidence is evidence of absence"?

Clin Exp Rheumatol. Sep-Oct 2004;22(5):651.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzbromarone / therapeutic use*
  • Drug Approval*
  • Europe
  • Gout / drug therapy*
  • Humans
  • Uricosuric Agents / therapeutic use*

Substances

  • Uricosuric Agents
  • Benzbromarone